Novum Pharmaceutical Research Services, a subsidiary of Lambda Therapeutic Research, is a CRO with over 50 years of experience in the industry. Lambda & Novum deliver comprehensive, end-to-end clinical research services to the innovator, biotech, and generic pharmaceutical industries worldwide.
We will be participating in the BIO International Convention, scheduled for June 16-19, 2025, in Boston, USA.
As a Trusted CRO Partner, Lambda & Novum delivers comprehensive, end-to-end clinical research services to the innovator, biotech, and generic pharmaceutical industries worldwide. With a focus on secure IT infrastructure and automation, Lambda ensures timely project delivery and strict adherence to global regulatory standards. Our exemplary regulatory track record includes over 60 successful international inspections and audits by esteemed authorities such as the USFDA, EMEA, MHRA, EU member states, and other global bodies over the past five years.
Lambda’s commitment to excellence has garnered significant recognition, including the ‘Best Indian CRO’ award from Frost & Sullivan (USA) and the ‘Great Indian Workplace’ title from UBS Transformance. Recent accolades include the ‘Regulatory Excellence’ Award at the CPhI Pharma Awards 2023 and the ‘Industry Partner of the Year’ Award at the Global Generics & Biosimilar Awards 2023.
Connect with us at BIO International Convention 2025
We look forward to showcasing how our extensive experience and expertise in drug development can drive your project’s success. Please drop us a line at to discuss how Lambda and Novum can support your drug development projects.